Literature DB >> 2596550

Ocular abnormalities in patients with beta thalassemia.

S Gartaganis1, K Ismiridis, O Papageorgiou, N G Beratis, D Papanastasiou.   

Abstract

We examined 29 patients with homozygous beta thalassemia. The mean age of the patients was 15.6 +/- 8.9 years. Twelve patients (mean age, 02.0 +/- 10.4 years) had one or more ocular abnormalities. Five patients had degeneration of the retinal pigment epithelium, one had lens opacities, two had lens opacities and degeneration of the retinal pigment epithelium, one had vascular abnormalities and degeneration of the retinal pigment epithelium, one had angioid streaks, lens opacities, and degeneration of the retinal pigment epithelium, and two had angioid streaks and degeneration of the retinal pigment epithelium. These abnormalities were observed in patients with both forms of beta thalassemia, major and intermedia. The frequency of the ocular abnormalities increased with age. The youngest patient with an ocular abnormality was 6 1/2 years old. There was no correlation between the abnormalities observed and the serum ferritin level, the mean hematocrit value, and the dose of deferoxamine given to the patients.

Entities:  

Mesh:

Year:  1989        PMID: 2596550     DOI: 10.1016/0002-9394(89)90864-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  A mouse model of β-thalassemia shows a liver-specific down-regulation of Abcc6 expression.

Authors:  Ludovic Martin; Vanessa Douet; Christopher M VanWart; Matthew B Heller; Olivier Le Saux
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 2.  Ocular abnormalities in beta thalassemia patients: prevalence, impact, and management strategies.

Authors:  Samira Heydarian; Reza Jafari; Kiumars Nowroozpoor Dailami; Hassan Hashemi; Ebrahim Jafarzadehpour; Mohsen Heirani; Abbasali Yekta; Monireh Mahjoob; Mehdi Khabazkhoob
Journal:  Int Ophthalmol       Date:  2019-10-10       Impact factor: 2.031

3.  Multiple transfused thalassemia major: ocular manifestations in a hospital-based population.

Authors:  Rashi Taneja; Pankaj Malik; Mamta Sharma; Mahesh C Agarwal
Journal:  Indian J Ophthalmol       Date:  2010 Mar-Apr       Impact factor: 1.848

4.  Ocular abnormalities in patients with beta thalassemia on transfusion and chelation therapy: our experience.

Authors:  Jitendra Jethani; Kenshuk Marwah; Shashank Patel; Bela Shah
Journal:  Indian J Ophthalmol       Date:  2010 Sep-Oct       Impact factor: 1.848

Review 5.  Retinal abnormalities in β-thalassemia major.

Authors:  Devang L Bhoiwala; Joshua L Dunaief
Journal:  Surv Ophthalmol       Date:  2015-08-29       Impact factor: 6.048

Review 6.  β-Thalassemia and ocular implications: a systematic review.

Authors:  Aliki Liaska; Petros Petrou; Constantinos D Georgakopoulos; Ramza Diamanti; Dimitris Papaconstantinou; Menelaos G Kanakis; Ilias Georgalas
Journal:  BMC Ophthalmol       Date:  2016-07-08       Impact factor: 2.209

7.  Ocular abnormalities in multi-transfused beta-thalassemia patients.

Authors:  Reza Jafari; Samira Heydarian; Hosein Karami; Mohammad Momeni Shektaei; Kiumars Noruzpour Dailami; Ahmad Ahmadzadeh Amiri; Majid Reza Sheikh Rezaee; Asad Allah Farrokh Far
Journal:  Indian J Ophthalmol       Date:  2015-09       Impact factor: 1.848

Review 8.  Potential Treatment of Retinal Diseases with Iron Chelators.

Authors:  Wanting Shu; Joshua L Dunaief
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.